Laurene Wang, PhD
CEO and Founder
AimMax® Therapeutics, Inc. (AimMax), is a company engaged in the research and development of biopharmaceuticals at various stages through in-licensing or co-development with strategic partners.
The company was founded in 2017 by pharmaceutical R&D professionals with diverse and synergistic backgrounds.
Company Core Strengths
Translational Medicine: To advance early-stage molecules, from lead optimization to clinical proof of principle by understanding the molecules, the science and disease models.
Clinical Trial Design and Operations: To incorporate innovate trial design and data analysis to maximize clinical trial efficiency and the success of pivotal trials.
Regulatory and Commercial Strategies: To position the product for optimal labeling and commercial potential.
Passion and Dedication: To benefit the patients and health care community.